Viatris environmental stewardship

Working to Advance Environmentally Sustainable Operations

We are committed to doing our part to advance sustainable practices and minimize our environmental footprint. Through our initial companywide sustainability goals and the work we do every day, we actively manage our impact on climate change, energy use, water management and air emissions.

Viatris sustainable partnerships

Environmental Stewardship

Working to ensure stable access to high-quality medicines depends upon continuously working to further advance responsible and sustainable operations. We do this across our global network by implementing technologies, processes and systems to minimize our impact on climate change, energy use, water withdrawal and air emissions. Our work as environmental stewards is governed by our global Environmental, Health and Safety (EHS) management system, principles and policies. In 2023, we made progress on our goals in the areas of climate, water and waste.

  • Our reduction targets for scope 1 and 2, and scope 3 GHG emissions have been approved and validated by the SBTi. We are making progress and believe our current strategy is on track to deliver on our reduction targets by 2030.
  • We performed six water risk assessments in 2023, bringing our total since 2022 to 11 water risk assessments completed.
  • Thirteen sites achieved zero-waste landfill status in 2023, with six additional sites at less than 5% of waste going to landfill.

Working to Reduce Emissions in Our Supply Chain

We are working to reduce carbon emissions across our supply chain. We work across all three of our freight transportation modes - road, ocean and air - to that end. Supply reliability and transport efficiency are primary objectives. We focus on full truck loads and double stacking of pallets where possible and partner with our freight partners to move from dedicated containers to sharing capacity with other companies to better utilize space across the industry. Full truck loads are considered the most efficient mode of transit.

In 2023, road and ocean represented 81% of all our transport. As timely access to medicine is the priority, there are exceptions when speed is of the essence and air transport may be required, representing 19% of our transport in 2023. As part of protecting supply reliability and reducing GHG emissions, we are looking into railway as another mode of transport. Further, we are looking at more sustainable packaging solutions to prepare our products for shipments.

Responsible Antibiotic Manufacturing

As Viatris, we are compliant with the AMRIA Antibiotic Manufacturing Standard for our own operations and committed to implementing it across our external supply chain. All applicable Viatris manufacturing locations with antibiotic production have been internally assessed and adhere to the AMRIA Antibiotic Manufacturing Standard, including meeting the PNEC (RQ<1) as calculated by mass balance.

Milestone Certification for Reducing the Risk of AMR in Manufacturing

Our manufacturing for all dosages of the antibiotic Ciprofloxacin at our facility in Aurangabad, India, became the first at Viatris to receive British Standards Institute (BSI) Certification under the Antibiotic Manufacturing Standard. It is also the only site in India to hold this certification.1 The BSI Kitemark™ for minimized risk of antimicrobial resistance provides independent, third-party assurance and demonstrates that antibiotic residue emissions from solid and liquid waste streams are effectively controlled during manufacturing.

1 as of February 2024

Working to Make a Difference

2023 Sustainability Report Cover

We work to continuously advance responsible and sustainable practices and operations and leverage our collective expertise to empower people worldwide to live healthier at every stage of life, recognizing that our actions affect the stakeholders and communities we serve.

Read the report
2023 Environmental Stewardship Fact Sheet